- Oops!Something went wrong.Please try again later.
NRZ earnings call for the period ending June 30, 2021.
Brian Sozzi, Julie Hyman, and Brian Cheung break down Monday’s trending tickers which include: Tesla shareholders receiving a recommendation to reject Kimbal Musk and Murdoch as board members, Morgan Stanley cutting Amazon’s price target as concerns over the company’s profitability take center stage, and Polestar partnering with Gores Guggenheim in a SPAC deal to go public.
The fascinating thing about General Electric (NYSE: GE), Johnson Controls (NYSE: JCI), and Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is that they have entirely different earnings drivers over the next decade. Former CEO Jeff Immelt has been widely criticized for making big bets on fossil fuel technologies. Unfortunately, the market for gas turbines halved in the years since the significant Alstom acquisition, as did the price of oil after Immelt made a slew of acquisitions.
The next iPhone will bring the first complete redesign to the line-up in years, according to a new report. The iPhone 13 has only been in shops for less than a week, but rumours are already beginning about what form its successor will take. The new line-up will include “new entry-level and Pro models and a complete redesign”, according to Bloomberg’s Mark Gurman, who has a strong track record of detailing Apple products before they are announced to the public.
In this article, we reviewed Bridgewater Associates founder Ray Dalio’s portfolio adjustment strategies to cope up with the market volatility. We also discussed the top ten stocks billionaire Ray Dalio is buying. You can skip our detailed discussion and jump directly to Billionaire Ray Dalio is Buying These 5 Stocks. Raymond Thomas Dalio’s $223 billion […]
Red Cat Holdings Inc (NASDAQ: RCAT) subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Simulated Mars mission. The financial terms of the transaction remain undisclosed. NASA's crew would conduct simulated spacewalks and operations by remote piloting Skypersonic drones and rovers in a simulated Martian environment. Skypersonic's Dronebox real-time transoceanic remote piloting platform will drive the piloting of both
Biotech stocks have been some of the most reliable capital-appreciation vehicles in the entire market for the past two decades. As proof, biotech equities such as CRISPR Therapeutics, Moderna, Novavax, Ocugen, and Vertex Pharmaceuticals -- just to name a few -- have all made their early shareholders market-crushing gains. Not all biotech stocks are cut from the same cloth, however.
(Bloomberg) -- Polestar, the electric-vehicle maker backed by Volvo Car Group and actor Leonardo DiCaprio, agreed to go public through a merger with a blank-check company at a roughly $20 billion enterprise valuation.Most Read from BloombergHow Los Angeles Became the City of DingbatsWhy the Gaza Strip May Be the City of the FutureSchool Reopenings Falter as U.S. Kids Near 1 Million Covid CasesThe Rise of the Pandemic DashboardA Jewish Tradition Makes Room for Unconventional DesignThe automaker f
When we took Simply Safe Dividends’ safety rankings and applied them to the S&P 500 Dividend Aristocrats, we learned that the best-yielding among the top scorers are mostly lagging behind the market. Plus, AT has a low safety score and earlier this year announced a dividend cut as part of an asset sale.
In this article, we discuss the 10 tech stocks hedge funds are buying instead of Microsoft. If you want to skip our detailed analysis of these stocks, go directly to Hedge Funds are Selling Microsoft and Buying These 5 Tech Stocks Instead. Microsoft Corporation (NASDAQ:MSFT) crossed $2 trillion in market capitalization in late June this […]
Shell is taking on the customers of collapsed energy company Green Supplier as the sector's crisis strengthens larger, more resilient players.
Investors love healthcare stocks in both bull markets and times of uncertainty, but not all investments are slam-dunks. The following three healthcare-related stocks have a handful of specific characteristics that make them great candidates to fulfill different roles in your investment portfolio. CVS Health (NYSE: CVS) is a diverse healthcare company that operates a chain of drugstores, a pharmacy benefits management business, and a major health insurance carrier since its 2017 acquisition of Aetna.
Boeing stock is higher after U.S. durable-goods orders for August 2021 blew past economist expectations Monday.
Dell Technologies (NYSE: DELL) shareholders are about to realize a corporate event they've been looking forward to for over a year now: the tax-free spinoff of Dell's 80.6% stake in virtualization software company VMware (NYSE: VMW). Dell's stock has already done quite well in 2021, up more than 40% on the year, in anticipation of the move. Last week, management held an analyst day, touting its outlook for the core business, as well as the future implementation of a large share repurchase plan and initiation of what looks to be a hefty future dividend.
The United Nations anticipates that the global population over the age of 65 is expected to surge from 727 million people in 2020 to over 1.5 billion people by 2050. Long-term investors should consider purchasing Amgen (NASDAQ: AMGN). There are 20 molecules currently in phase 1 clinical trials and 19 molecules in phase 2 or 3 clinical trials.
Online delivery, social media apps and software are hot stocks for the growth fund manager who says value companies are about to take a back seat.
“You only get one shot” Eminem famously sang on “Lose Yourself.” That might have been true in the cutthroat music business the Detroit rapper was trying to break into, but the nice thing for investors is that Eminem’s problem doesn’t apply to the stock market. While investors constantly rue missed opportunities, ruminating on a never-ending list of “if onlys,” the fact is there are always new opportunities in the public markets, it’s just finding them that’s the problem. A helping hand here woul
It sounds like you may need a third party — a financial adviser or financial therapist — to show you on paper that you can afford to live within your means for many years to come. Having a worthy financial goal will give you something solid to focus on, instead of a blank canvas of what could happen in the future.
Buying stocks can benefit investors of all ages. And the younger you are the more time is available for those investments to compound. But today's market full of biotech and artificial intelligence companies can be intimidating for those a little later in their investing journey.
Here's why Wall Street thinks Teladoc stock could soar 44% higher within the next year. To be sure, several analysts expect that Teladoc Health will continue to face some headwinds this year. Teladoc recently signed a major agreement with Health Care Service Corporation (HCSC), the fifth-largest health insurer in the U.S., to provide chronic care solutions to HCSC members.
With that in mind, we asked three Motley Fool contributors to highlight one stock that's already a tremendous run so far this year that they'd buy today. Danny Vena (Global-E Online): There's little doubt e-commerce has a long runway ahead. The company handles many of the challenges and complexities that come with international selling, leaving the merchant to go about their daily routine.